Cargando…

Use of tumor necrosis factor alpha (TNF α) antagonists in a patient with psoriasis and Chagas disease

There are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarrete-Dechent, Cristián, Majerson, Daniela, Torres, Marisa, Armijo, Daniela, Patel, Mahir, Menter, Alan, de la Cruz, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Dermatologia 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540541/ https://www.ncbi.nlm.nih.gov/pubmed/26312707 http://dx.doi.org/10.1590/abd1806-4841.20153538

Ejemplares similares

Emerging Therapies for the Treatment of Psoriasis
por: Patel, Mahir, et al.
Publicado: (2012)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
por: Sharma, Neel, et al.
Publicado: (2009)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Chronic Ulcer on the Tongue as a Manifestation of Histoplasmosis During Anti-tumor Necrosis Factor-Alpha (TNF-⍺) Inhibitor Therapy for Psoriasis
por: Harrison, Iris, et al.
Publicado: (2023)

Is It Possible to Discontinue Tumor Necrosis Factor Antagonists after Psoriasis Remission?
por: Kim, Byungsoo, et al.
Publicado: (2019)

Switching from a first to a second tumour necrosis factor (TNF) alpha antagonist in patients with juvenile idiopathic arthritis
por: Schmeling, H, et al.
Publicado: (2008)

Serum Levels of Tumor Necrosis Factor - alpha in Patients With Psoriasis
por: Ovcina-Kurtovic, Nermina, et al.
Publicado: (2022)

Paradoxical Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor-Induced Psoriasis: A Systematic Review of Pathogenesis, Clinical Presentation, and Treatment
por: Chokshi, Aditi, et al.
Publicado: (2023)

Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide
Publicado: (1990)

Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke
por: Cui, Guanglin, et al.
Publicado: (2012)

Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists
por: Wu, Chun-Ying, et al.
Publicado: (2016)

Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2
por: Pircher, Joachim, et al.
Publicado: (2012)

Adalimumab for severe psoriasis in Chilean paediatric patients()()
por: Armijo Fernandez, Daniela, et al.
Publicado: (2020)

Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series()
por: Megna, Matteo, et al.
Publicado: (2022)

Autocrine self-elimination of cultured ovarian cancer cells by tumour necrosis factor alpha (TNF-alpha).
por: Simonitsch, I., et al.
Publicado: (1998)

Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma
por: Brierly, Gary, et al.
Publicado: (2023)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021)

Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55
Publicado: (1993)

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
por: Valenzuela, Fernando, et al.
Publicado: (2022)

The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
por: Manzo, Ciro, et al.
Publicado: (2022)

Polymorphisms in the tumor necrosis factor alpha (TNF-alpha) gene correlate with murine resistance to development of toxoplasmic encephalitis and with levels of TNF-alpha mRNA in infected brain tissue
Publicado: (1992)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch, Dario, et al.
Publicado: (2014)

Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date
por: Kivelevitch, Dario, et al.
Publicado: (2019)

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
Publicado: (1991)

A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
por: Zhang, Feixu, et al.
Publicado: (2019)

Polymorphisms in Tumour Necrosis Factor Alpha (TNFα) Gene in Patients with Acute Pancreatitis
por: Özhan, Gül, et al.
Publicado: (2010)

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
por: Menter, Alan
Publicado: (2023)

Scabies Mite is Bright Green Under UV Dermatoscopy
por: Pietkiewicz, Paweł, et al.
Publicado: (2023)

Overdiagnosis of Melanoma: Is It a Real Problem?
por: Navarrete-Dechent, Cristian, et al.
Publicado: (2023)

Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options
por: Menter, Alan, et al.
Publicado: (2021)

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists
por: Urbano, Paulo César Martins, et al.
Publicado: (2014)

Glial Tumor Necrosis Factor Alpha (TNFα) Generates Metaplastic Inhibition of Spinal Learning
por: Huie, J. Russell, et al.
Publicado: (2012)

Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species
por: Ardestani, Shidrokh, et al.
Publicado: (2013)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon
Publicado: (1994)

Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy
por: Leboime, Ariane, et al.
Publicado: (2009)

Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine
por: Tariq, Zeshan, et al.
Publicado: (2019)

Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist
por: Hayashida, Sho, et al.
Publicado: (2020)

Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression
por: Bosch-Nicolau, Pau, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_87sgo6f4nhuski6bq4duvic2dd